NUE
39
-4
EXPD
37
-2
LEN
45
3
MAS
52
-2
TAP
60
2
ORCL
52
-7
IPG
49
2
GME
54
-3
CMS
57
3
VTR
43
-3
EA
50
-2
PNR
66
-3
AVGO
88
27
HAS
32
-5
CA
25
-7
EQIX
60
-3
ALL
41
6
MCO
74
-3
UHS
52
2
AAP
29
-3
NUE
39
-4
EXPD
37
-2
LEN
45
3
MAS
52
-2
TAP
60
2
ORCL
52
-7
IPG
49
2
GME
54
-3
CMS
57
3
VTR
43
-3
EA
50
-2
PNR
66
-3
AVGO
88
27
HAS
32
-5
CA
25
-7
EQIX
60
-3
ALL
41
6
MCO
74
-3
UHS
52
2
AAP
29
-3
Financhill
Back

BioNexus Gene Lab Quote, Financials, Valuation and Earnings

The dark truth about AI

Click here to learn more...
Sell
36

BGLC
BioNexus Gene Lab

Last Price:
0.26
Seasonality Move:
-23.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

BioNexus Gene Lab Price Quote

$0.26
0.00 (-4.06%)
(Updated: December 14, 2024 at 5:25 AM ET)

BioNexus Gene Lab Key Stats

Sell
36
BioNexus Gene Lab (BGLC) is a Sell
Day range:
$0.26 - $0.28
52-week range:
$0.23 - $3.39
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.50
P/B ratio:
0.5%
Volume:
39.5K
Avg. volume:
1M
1-year change:
-61.61%
Market cap:
$4.7M
Revenue:
$9.8M
EPS:
$-0.07

How Much Does BioNexus Gene Lab Make?

Is BioNexus Gene Lab Growing As A Company?

  • What Is BioNexus Gene Lab's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.03%
  • What Is BioNexus Gene Lab's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

BioNexus Gene Lab Stock Price Performance

  • Did BioNexus Gene Lab Stock Go Up Last Month?
    BioNexus Gene Lab share price went down by -19.55% last month
  • Did BGLC's Share Price Rise Over The Last Year?
    BGLC share price fell by -61.61% over the past 1 year

What Is BioNexus Gene Lab 52-Week High & Low?

BioNexus Gene Lab Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy BioNexus Gene Lab?

  • How Much Debt Does BioNexus Gene Lab Have?
    Total long term debt quarterly is $0
  • How Much Cash Does BioNexus Gene Lab Have?
    Cash and short term investments quarterly total is $4.1M
  • What Is BioNexus Gene Lab’s Book Value Per Share?
    Book value per share is 0.52

Is BioNexus Gene Lab Cash Flow Positive?

  • What Is BGLC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$2.4M
  • What Is BioNexus Gene Lab’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $9.5K
  • What Is BioNexus Gene Lab’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$89.7K

BioNexus Gene Lab Return On Invested Capital

  • Is Management Doing A Good Job?
    BGLC return on invested capital is -9.89%
  • What Is BioNexus Gene Lab Return On Assets?
    ROA measures how assets are converting to revenues and is -8.38%
  • What Is BGLC Return On Equity?
    ROE is a measure of profitability and is -9.89%

BioNexus Gene Lab Earnings Date & Stock Price

BioNexus Gene Lab Competitors

  • Who Are BioNexus Gene Lab's Competitors?
    Below is a list of companies who compete with BioNexus Gene Lab or are related in some way:
    • Golden Minerals Co (AUMN)
    • Balchem Corp (BCPC)
    • Friedman Industries Inc (FRD)
    • Paramount Gold Nevada Corp (PZG)
    • Solitario Resources Corp (XPL)

BioNexus Gene Lab Dividend Yield

BioNexus Gene Lab Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 3% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many BGLC shares are owned by institutional investors?
    181.4K BGLC shares are owned by institutional investors
  • How many BGLC shares are owned by insiders?
    17.3M BGLC shares are owned by insiders